SPC98 Antibody

What is SPC98 and why is it important in cell biology?

SPC98 is a protein component of the spindle pole body (SPB) in yeast and the centrosome in humans that forms part of a complex with γ-tubulin and other proteins essential for microtubule nucleation. In Saccharomyces cerevisiae (baker's yeast), SPC98 (also known as Spc98p) functions as part of a trimeric complex with Tub4p (yeast γ-tubulin) and Spc97p . This protein plays a critical role in organizing the microtubule cytoskeleton, which is fundamental to numerous cellular processes including chromosome segregation during cell division. The importance of SPC98 is underscored by its evolutionary conservation, with homologues identified in humans exhibiting functional similarity despite relatively low sequence identity (22% identity, 45% similarity) .

What are the key characteristics of commercially available SPC98 antibodies?

Commercial SPC98 antibodies are typically produced as polyclonal antibodies raised in rabbits against recombinant Saccharomyces cerevisiae SPC98 protein. These antibodies are generally purified through antigen affinity methods and formulated in storage buffers containing glycerol and preservatives such as Proclin 300 . They are primarily designed for research applications including Western blotting (WB) and enzyme-linked immunosorbent assay (ELISA) . The antibodies recognize SPC98 from specific strains such as Saccharomyces cerevisiae strain ATCC 204508/S288c, though cross-reactivity with SPC98 homologues from other species may vary between products and should be validated experimentally for each application .

How is SPC98 protein structurally and functionally related between yeast and human systems?

While the sequence similarity between yeast and human SPC98 is moderate (22% identity, 45% similarity), their functional conservation is remarkable . Both proteins localize to microtubule organizing centers—the spindle pole body in yeast and the centrosome in humans—and participate in γ-tubulin complexes essential for microtubule nucleation. Human SPC98 cDNA exhibits alternative splicing at the 3' end, indicating potential functional diversity not observed in yeast . Despite structural differences, functional studies using affinity-purified antibodies against SPC98 demonstrate that both yeast and human homologues are required for microtubule nucleation, as evidenced by inhibition of this process when antibodies are introduced to isolated centrosomes or microinjected into cells .

What evidence supports SPC98's role in microtubule nucleation?

Several experimental approaches have established SPC98's critical role in microtubule nucleation. Immunodepletion studies using affinity-purified antibodies against SPC98 demonstrate inhibition of microtubule nucleation on isolated centrosomes . Additionally, microinjection of these antibodies into cells prevents proper microtubule organization . In yeast, genetic studies with temperature-sensitive mutants and the characterization of protein complexes containing SPC98, Tub4p, and Spc97p further confirm this protein's essential function in microtubule nucleation at the spindle pole body . The co-localization of SPC98 with γ-tubulin at centrosomes and their presence in the same cytosolic complexes (as demonstrated through sucrose gradient sedimentation and immunoprecipitation experiments) provides additional evidence for SPC98's role in this fundamental cellular process .

How does phosphorylation regulate SPC98 function and localization?

Phosphorylation of SPC98 appears to be spatially and temporally regulated in a manner that affects its function. In yeast, Spc98p is phosphorylated at the nuclear side of the spindle pole body (SPB) but not at the cytoplasmic side . This phosphorylation occurs in a cell cycle-dependent manner, suggesting regulation of SPC98 activity during specific phases of mitosis. Interestingly, when SPC98 exists in cytoplasmic complexes with Tub4p and Spc97p, it remains predominantly in its unphosphorylated form . This indicates that phosphorylation is not required for complex formation or nuclear import but may instead regulate the protein's activity at the SPB. The kinases responsible for this modification and the specific phosphorylation sites remain areas for further investigation, particularly regarding whether similar regulatory mechanisms exist for the human homologue and how they might influence centrosome maturation and microtubule nucleation capacity .

What is known about the SPC98 nuclear localization signal (NLS) and its importance?

SPC98 contains a functional nuclear localization signal (NLS) that is essential for its proper cellular function. Detailed studies in yeast have identified specific regions of the Spc98p protein (particularly NLS4 and NLS5) that, when mutated, prevent nuclear import of the protein . These NLS-defective mutants localize exclusively to the cytoplasmic outer plaque of the spindle pole body, as demonstrated by immunoelectron microscopy, while wild-type SPC98 associates with both inner and outer plaques . The functional significance of this nuclear targeting is highlighted by the observation that NLS-defective mutants lose their biological activity. Furthermore, the SPC98 NLS appears to facilitate the nuclear import of the entire complex containing Tub4p and Spc97p, as these proteins form complexes with SPC98 in the cytoplasm and depend on SPC98's NLS for proper nuclear localization .

How can researchers distinguish between SPC98's cytoplasmic versus centrosomal/SPB functions?

Distinguishing between SPC98's cytoplasmic and centrosomal/SPB functions requires sophisticated experimental approaches. Subcellular fractionation techniques have been used to carefully separate cytoplasmic and nuclear components while maintaining protein complexes intact . Such approaches have revealed that SPC98 exists in both locations but in different states—the cytoplasmic form is predominantly unphosphorylated and complexed with Tub4p and Spc97p, while the centrosomal/SPB-associated form shows cell cycle-dependent phosphorylation . Immunoelectron microscopy provides high-resolution localization data, demonstrating SPC98's presence at specific SPB structures (inner versus outer plaques) . Additionally, mutational analysis of the nuclear localization signal has created tools to manipulate SPC98's distribution, allowing researchers to assess the functional consequences of restricting the protein to the cytoplasm . Combined with immunoprecipitation to characterize protein-protein interactions in different cellular compartments, these approaches offer complementary insights into SPC98's location-specific functions.

What are the protein-protein interaction domains of SPC98 and their functional significance?

SPC98 contains distinct domains that mediate specific protein-protein interactions essential for its function in microtubule nucleation. Two-hybrid system experiments have identified that the C-terminal domain of SPC98 specifically interacts with Tub4p (yeast γ-tubulin), while the central domain interacts with Spc97p . These interaction domains enable SPC98 to serve as a scaffold in the formation of the trimeric Tub4p complex. The functional significance of these interactions extends beyond complex assembly to nuclear import, as the binding of SPC98 to Tub4p and Spc97p in the cytoplasm facilitates the nuclear import of all three proteins via SPC98's nuclear localization signal . Mutations that disrupt these protein-protein interactions would therefore be expected to impair not only complex formation but also proper subcellular localization and ultimately microtubule nucleation capability. Understanding these interaction domains provides potential targets for experimental manipulation of the complex's assembly and function.

What are the optimal conditions for using SPC98 antibodies in immunoprecipitation experiments?

For successful immunoprecipitation of SPC98 and its associated proteins, several methodological considerations are critical. Based on published protocols, effective immunoprecipitation of yeast SPC98 has been achieved using the following approach: Cells should be lysed in buffer containing 100 mM NaCl, 1% Triton X-100, 15 mM Tris-Cl (pH 7.5), 0.1% SDS, and protease inhibitors . After initial clarification, dilution of the lysate (20x) with 150 mM NaCl, 1% Triton X-100, 15 mM Tris-Cl (pH 7.5), and 0.1% SDS helps reduce background . Pre-clearing with protein-G Sepharose is recommended before adding specific antibodies (such as 12CA5 for HA-tagged SPC98) . To further reduce non-specific binding, protein-G Sepharose beads should be precoated with buffer containing 1% bovine serum albumin, and addition of unlabeled protein extract from wild-type strains can compete away non-specific interactions . Sequential washing with increasingly stringent buffers is crucial for specific recovery while maintaining protein-protein interactions within the SPC98 complex .

How can researchers effectively detect phosphorylated versus unphosphorylated forms of SPC98?

Distinguishing between phosphorylated and unphosphorylated forms of SPC98 requires careful experimental approaches. SDS-PAGE analysis reveals phosphorylated SPC98 as a band with reduced electrophoretic mobility compared to the unphosphorylated form . For more definitive identification, researchers should consider: (1) Phosphatase treatment of immunoprecipitated SPC98 to confirm that mobility shifts are due to phosphorylation; (2) Subcellular fractionation to separate nuclear and cytoplasmic pools, as phosphorylation appears to be compartment-specific; (3) Cell synchronization to examine cell cycle-dependent changes in phosphorylation status . Additionally, phospho-specific antibodies may be developed by immunizing animals with phosphopeptides corresponding to predicted or identified phosphorylation sites on SPC98. Mass spectrometry analysis of immunoprecipitated SPC98 can identify specific phosphorylation sites and their occupancy. These approaches can be complemented by genetic studies using phospho-mimetic or phospho-deficient mutants to assess the functional significance of specific phosphorylation events.

What controls and validation steps should be included when using SPC98 antibodies?

Proper experimental controls and validation are essential when working with SPC98 antibodies to ensure specific detection and accurate interpretation of results. Critical controls include: (1) Negative controls using cells or tissues lacking SPC98 expression or samples from SPC98 knockout organisms when available; (2) Peptide competition assays where the antibody is pre-incubated with excess recombinant SPC98 or the immunogenic peptide to confirm signal specificity; (3) Comparison of results using multiple antibodies targeting different epitopes of SPC98 . For validation in immunolocalization studies, co-staining with established centrosome/SPB markers provides confirmation of proper targeting . When using tagged versions of SPC98 (e.g., HA-tagged), parallel detection with both anti-tag and anti-SPC98 antibodies can verify specificity . Additionally, validation should include testing for cross-reactivity with related proteins, especially when studying SPC98 across different species given the moderate sequence conservation between homologues .

How can immunoelectron microscopy be optimized for SPC98 localization at centrosomes/SPBs?

Optimizing immunoelectron microscopy for precise SPC98 localization at centrosomes/SPBs requires attention to several technical details. Sample preparation is critical—cells should be fixed with a combination of paraformaldehyde (2-4%) and low concentrations of glutaraldehyde (0.1-0.2%) to preserve antigenicity while maintaining ultrastructural integrity . For yeast cells, spheroplasting before fixation improves antibody penetration. Embedding in LR White or similar hydrophilic resins is preferable to traditional epoxy resins as they better preserve antigenicity. Ultrathin sections (60-80 nm) mounted on nickel grids facilitate optimal visualization . For immunolabeling, diluted primary antibodies against SPC98 (typically 1:50 to 1:200) should be applied followed by gold-conjugated secondary antibodies (typically 5-15 nm gold particles) . Controls must include omission of primary antibody and use of non-immune serum. For multi-labeling experiments to co-localize SPC98 with other proteins, different sized gold particles can be used for distinct antibodies. Quantification should include statistical analysis of gold particle distribution relative to defined SPB/centrosome substructures across multiple cells to establish significance of localization patterns .

How can SPC98 antibodies be used to study microtubule nucleation mechanisms?

SPC98 antibodies provide powerful tools for dissecting microtubule nucleation mechanisms through several experimental approaches. Function-blocking experiments, where affinity-purified SPC98 antibodies are microinjected into cells or added to isolated centrosomes in microtubule regrowth assays, can directly demonstrate SPC98's requirement for nucleation . These antibodies can also be used in cell-free systems reconstituted with purified components to determine the minimal machinery necessary for nucleation. Immunodepletion of SPC98 from Xenopus egg extracts or other cell-free systems, followed by complementation with wild-type or mutant proteins, allows detailed mechanistic studies . For quantitative analysis, researchers can combine SPC98 immunostaining with high-resolution microscopy and automated image analysis to correlate SPC98 levels at centrosomes with nucleation capacity. Super-resolution microscopy approaches using SPC98 antibodies can reveal the nanoscale organization of nucleation complexes. Additionally, SPC98 antibodies enable the isolation of intact nucleation complexes for structural studies using electron microscopy or cryo-EM, providing insights into the molecular architecture of these essential cellular machines.

What are the key considerations when comparing SPC98 function across different model organisms?

When comparing SPC98 function across different model organisms, researchers must account for several important factors. First, sequence divergence between homologues (e.g., 22% identity between yeast and human SPC98) necessitates careful antibody selection or development of species-specific reagents . Second, structural differences between yeast spindle pole bodies and metazoan centrosomes must be considered when interpreting localization data. Third, while core functions in microtubule nucleation appear conserved, regulatory mechanisms may differ—yeast Spc98p shows cell-cycle dependent phosphorylation at the nuclear side of the SPB, but equivalent regulatory mechanisms in other organisms require verification . Fourth, differences in experimental approaches (e.g., genetic manipulation in yeast versus RNAi in mammalian cells) complicate direct comparisons of phenotypes. Fifth, the presence of alternative splicing in human SPC98 but not in yeast suggests additional functional complexity in higher eukaryotes . Finally, research must consider that interacting partners may have evolved different binding specificities or additional functions. Cross-species complementation experiments, where SPC98 from one organism is expressed in another, provide valuable insights into functional conservation and divergence.

How does the Xenopus sperm centrosome model inform our understanding of SPC98 function?

The Xenopus sperm centrosome provides a unique model system that has yielded important insights into SPC98 function during centrosome activation. Xenopus sperm centrosomes are initially incompetent for microtubule nucleation but become activated upon exposure to egg cytoplasm during fertilization . Remarkably, studies have shown that these inactive centrosomes contain similar amounts of both SPC98 and γ-tubulin compared to active human somatic centrosomes . This observation suggests that the mere presence of these proteins is insufficient for nucleation activity, and that additional regulatory mechanisms must control centrosome activation. These findings indicate that post-translational modifications, conformational changes, or recruitment of additional factors—rather than simply the recruitment of SPC98 and γ-tubulin—are likely critical for activating nucleation capacity. The Xenopus system thus provides a powerful experimental paradigm for distinguishing between the presence of nucleation components and their functional state, offering opportunities to identify the molecular switches that control microtubule organizing center activity.